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Plant pollens are an important source of environmental antigens that stimulate allergic 
responses. In addition to acting as vehicles for foreign protein antigens, they contain lipids 
that incorporate saturated and unsaturated fatty acids, which are necessary in the 
reproduction of higher plants. The CD1 family of nonpolymorphic major histocompatibility 
complex–related molecules is highly conserved in mammals, and has been shown to present 
microbial and self lipids to T cells. Here, we provide evidence that pollen lipids may be 
recognized as antigens by human T cells through a CD1-dependent pathway. Among 
phospholipids extracted from cypress grains, phosphatidyl-choline and phosphatidyl-
ethanolamine were able to stimulate the proliferation of T cells from cypress-sensitive 
subjects. Recognition of phospholipids involved multiple cell types, mostly CD4
 
 
 
 T cell receptor 
for antigen (TCR)
 
  
 
 
 
, some CD4
 
 
 
CD8
 
 
 
 TCR
 
  
 
 
 
, but rarely V
 
 
 
24
 
i
 
 
 
 natural killer–T cells, and 
required CD1a
 
 
 
 and CD1d
 
 
 
 antigen presenting cell. The responding T cells secreted both 
interleukin (IL)-4 and interferon-
 
 
 
, in some cases IL-10 and transforming growth factor-
 
 
 
, 
and could provide help for immunoglobulin E (IgE) production. Responses to pollen 
phospholipids were maximally evident in blood samples obtained from allergic subjects during 
pollinating season, uniformly absent in 
 
Mycobacterium tuberculosis
 
–exposed health care 
workers, but occasionally seen in nonallergic subjects. Finally, allergic, but not normal subjects, 
displayed circulating specific IgE and cutaneous weal and flare reactions to phospholipids.
 
The mechanisms of recognition of pollen
grains as allergens by the immune system have
been debated for a considerable time, and be-
cause most of the proteins described as sensi-
tizing agents are contained inside the intine
membrane and/or in the cytoplasmic region,
it is difficult to explain their rapid delivery in
vivo to the host immune system (1, 2). Tradi-
tional models suggest that nonspecific recep-
tors such as C-type lectins and integrins bind
surface glycoproteins, favoring phagocytosis by
alveolar macrophages of the whole pollen
grain and/or of starch granules (
 
 
 
5 
 
 
 
m) derived
from grasses (3). This in turn permits direct
interaction  of TCRs with antigen-derived
peptides presented by MHC-encoded anti-
gen-presenting molecules, consistent with the
current central paradigm for antigen presenta-
tion to T cells (4).
However, peptides are not the sole physio-
logical target of T cell responses, as T cells can
recognize a variety of lipid antigens by means
of CD1 proteins, a family of nonpolymorphic
antigen presenting molecules (5) that have
evolved to present lipids and glycolipids to the
mammalian immune system (6, 7). Of the
many potential immune functions for CD1, a
compelling case can be made for a role in host
defense, especially against intracellular patho-
gens (8). In addition, CD1-restricted T cells
are involved in regulation of autoimmune re-
sponses (9, 10) and in immunosurveillance
against tumors (11). Human CD1 genes on
chromosome 1 encode a diversified family of
proteins that are subdivided into group I (in-
cluding CD1a, -b, and -c) and group II
(CD1d; reference 12). The CD1 proteins are
expressed on professional APCs (13), and can
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present bacterial or synthetic lipids and glycolipids to various
T cell subpopulations (14, 15), which in turn mediate effec-
tor functions including cytolysis and IFN-
 
 
 
 secretion that
are known to be protective for the host (16).
Currently, it is not known if natural lipids from nonbacte-
rial and/or nonmammalian species may be recognized as anti-
gens in a CD1-restricted fashion by the human immune sys-
tem, apart from the glycolipid 
 
 
 
-galactosyl ceramide (17). In
mice, V
 
 
 
14
 
i
 
 NKT cells can recognize ceramide-based gly-
colipids as well as synthetic PL antigens in a CD1d-restricted
manner (18), and have recently been demonstrated as funda-
mental for the development of allergen-induced airway hy-
perreactivity (19). This suggested to us the possibility that lip-
ids contained within pollen grains, a source of environmental
antigens that are frequently associated with airway hyperreac-
tivity in humans, might be capable of activating CD1-re-
stricted T cell responses. Pollen grains are known to contain
many unsaturated fatty acids that are necessary to allow pollen
germination, and these could potentially contribute to the im-
munogenicity of CD1-presented lipid antigen (20–22).
Our results suggest that phospholipids (PLs) at the pollen
surface may be of functional relevance for the capture of the
pollen grain by APCs and its recognition by the immune
system of sensitive subjects. T cell clones specific for pollen
PLs possessed functional properties similar to those of regula-
tory T cells, secreted both Th1 and Th2 type cytokines and
displayed helper activity for IgE production. Thus, CD1-
restricted PL-specific T cells could have a central role in reg-
ulating the immune response in allergic individuals.
 
RESULTS
A possible role for CD1a and CD1d molecules in capture 
of cypress pollen
 
Both upper (23) and lower airways (24) are known to con-
tain large numbers of DCs and macrophages, which are cell
types that have the potential to express CD1 proteins. Previ-
ous studies have reported the frequent expression of CD1a
on airway derived DCs from allergic subjects (25). We ex-
tended these observations by examining the presence of
CD1d on DCs or other types of mononuclear cells in the
airways, and sought to determine if the expression of CD1
proteins could be relevant to the capture of pollens in vivo
and in vitro. Immunophenotyping of bronchoalveolar lavage
(BAL)-derived mononuclear cells revealed the presence of
CD11c
 
 
 
CD86
 
 
 
 DCs in asthmatic subjects, as compared
with healthy controls (unpublished data), thus confirming
the existence in the airways of atopic individuals of profes-
sional APCs (23–25). As shown in Fig. 1 a, a variety of
Figure 1. Interactions between cypress pollen and CD1d  DCs. 
Pollen capture in vivo. (a) The pollen grain constituted by a dark blue 
exine envelope with extruded cytoplasmic material as appear in a BAL, 
sampled during pollinating season (May-Grünwald-Giemsa; 400 ). The 
cellular infiltrate contains pulmonary DCs, macrophages, and lympho-
cytes. (b) A BAL cytospin sample, representative of those obtained from 
controls (n   10), as it appeared after labeling with anti–human CD1d 
mAb (clone NOR3.2, working dilution 1:10) and staining with alkaline 
phosphatase/antialkaline phosphatase technique. Cells with morphology 
consistent with macrophages and DCs did not show surface or intracellular 
staining. (c) CD1d  APC in BAL cytospin from an allergic patient repre-
sentative of all samples obtained from all allergic subjects (n   15). 
(d) Pollen grain stained with fluorescein diacetate (0.1 mM); (e) DC stained 
with lipophylic dye 4-[4-(dihexadecylamino)styryl]-N-methylquinolinium 
iodine (DiQ; 1 mM); (f) a DiQ-labeled (red) DC after coculture with fluorescein 
diacetate–labeled (green) pollen grain for 15 min. Labeled fragments of 
the pollen grain have colocalized with DiQ-labeled membranes, as evi-
denced by the merged orange color. 
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mononuclear cell types present in BAL samples of asthmatic
subjects were able to interact with inhaled pollen grains. In
addition, staining with a CD1d-specific mAb revealed that
many strongly CD1d
 
 
 
 cells with morphology consistent
with macrophages or DCs were present in the BAL suspen-
sions from asthmatic subjects but not in BAL from normal
controls (Fig. 1, b and c). Using confocal fluorescence mi-
croscopy, we then followed pollen grain capture by in vitro
activated CD1
 
 
 
 DCs. Intact pollen grains were first labeled
using fluorescein diacetate (Fig. 1 d), and then combined
with monocyte-derived DCs previously stained with DiQ
{4-[4-(dihexadecylamino)styryl]-
 
N
 
-methylquinolinium io-
dide} (Fig. 1 e) to highlight both the surface and internal
membranes of the cells. The subsequent ingestion of the flu-
orescent grain was evident starting at 15 min after incuba-
tion, with a progressive concentration over time within cy-
toplasmic vesicles and cell membranes (Fig. 1 f).
Adopting an in vitro culture system, we found that
monocyte-derived DCs that expressed detectable surface lev-
els of multiple CD1 proteins (Fig. 2 a) could efficiently bind
pollen grains in vitro
 
.
 
 This interaction could be blocked by
preincubation of DCs with antibodies directed against the cell
surface–expressed conformation of CD1d and, to a lesser ex-
tent, CD1a proteins. In contrast, a nonbinding control Ig or
mAbs specific for MHC class I, CD1b, or CD1c molecules
had no effect on pollen binding by the cells (Fig. 2 b). Be-
cause polar lipids, and particularly PLs, may bind the hydro-
phobic pocket of CD1a and CD1d molecules (16, 26), we
tested the ability of lipids extracted from cypress pollen to sat-
urate CD1 receptors on DCs and thereby block pollen grain
binding. Only polar PL extract was able to inhibit pollen
grain adhesion to DCs, as compared with the neutral lipid or
protein pollen extract (Fig. 2 c). However, because DCs use
multiple redundant surface receptors to bind foreign sub-
stances, many of which functionally recognize hydrophobic
portions of both protein and lipid molecules (27), we also
tested the ability of CD1 expression in a nonphagocytic cell
type to mediate pollen grain binding to the cell surface. HeLa
cells, a transformed human cell line of epithelial origin, that
were stably transfected for expression of CD1d could bind
cypress pollen grains, whereas mock-transfected HeLa cells
that did not express CD1 showed minimal binding (Fig. 2 d).
Such binding could be inhibited by pretreatment of the
CD1d-transfected HeLa cells with mAbs against CD1d, but
was unaffected by pretreatment with mAbs against other
CD1 molecules or nonbinding control Ig. In addition, pre-
treatment of CD1d
 
 
 
 HeLa cells with cypress PLs could par-
tially (69 
 
 
 
 7%) inhibit this interaction. Collectively, these
data indicated that DCs bound pollen grains by specific inter-
action of CD1 molecules with surface PLs.
 
Analysis of PL components of cypress pollen
 
To identify specific ligands that might mediate this interac-
tion, we performed a direct chemical analysis of isolated cy-
Figure 2. CD1-dependence of pollen capture in vitro. (a) Expression 
of CD1 receptors on monocyte-derived DCs. (b) Pre-treatment of DCs with 
anti-human CD1d and anti-CD1a mAbs (20  g/ml) was able to inhibit 
adherence of pollen grains to DCs (*, P   0.005). Results are expressed as 
mean percentages ( SD) of inhibition with respect to samples incubated 
with control Ig. (c) Polar PLs, as opposed to neutral lipids or protein extract 
from cypress pollen, were able to saturate CD1 receptors on DCs at a con-
centration of 10  g/ml, thus preventing further grain capture (*, P   0.005). 
(d) HeLa CD1d transfectants bound cypress pollen grains and such binding 
could be specifically inhibited by preincubation with anti-CD1d mAb 
(*, P   0.005). For each of the 10 different preparations, 500 cells were 
counted by each of three independent observers, who were blinded to the 
identity of the samples. 
T CELL RECOGNITION OF LIPIDS FROM POLLENS | Agea et al.
 
298
 
press pollen lipids. Two-dimensional TLC of the lipid com-
position of the membranes from 
 
Cupressus arizonica
 
 and
 
Cupressus sempervirens
 
 pollens showed a variety of PLs (Fig. 3
a) that were similar to those previously described for 
 
Typha
latifolia
 
 or 
 
Brassica napus
 
 pollens (28, 29). Phosphatidyl-cho-
line (PC) represented greater than 50% of total PL, followed
by phosphatidyl-ethanolamine (PE; 15%) and then smaller
amounts of the other PL classes.
Molecular species compositions of TLC-purified pollen
PC and PE were determined by tandem mass spectrometry
(MS)/MS. Precursor scans for molecules giving rise after col-
lision-induced fragmentation to a protonated phosphocho-
line head group with m/z 184
 
 
 
 allowed identification and
structural determination of the PC molecules (Fig. 3 b, top
panel). Similarly, molecules characterized by the neutral loss
of phosphoethanolamine (m/z 141
 
 
 
; not depicted) were
analyzed by collision-induced dissociation MS to resolve the
precise structure of diacyl PE species (Fig. 3 b, middle
panel). Inspection of the electrospray ionization (ESI)
 
 
 
 scan
confirmed the absence of either plasmenyl or plasmanyl PE
species. The molecular species components of the major ions
present in the PC and PE spectra were identified by product
ion scans of the [M-15]
 
 
 
 ion for PC and the [M-H]
 
 
 
 ion for
PE (Fig. 3 b, bottom four panels). Both PC and PE compo-
sitions exhibited a restricted distribution dominated by spe-
cies containing the fatty acid linoleate (C18:2
 
n-6
 
), such that
the major species in each case was dilinoleoyl (18:2/18:2).
There were no disaturated or monounsaturated species in ei-
ther PC or PE from pollen.
 
CD1-restricted T cell responses against pollen-derived PLs
 
T cell lines from cypress-sensitive subjects displayed signifi-
cant in vitro proliferative responses mainly to cypress PE
and, to a lesser extent, PC (Fig. 3 c). These responses ap-
peared to be specific, because neither PE nor PC stimulated
proliferation of a panel of other human T cell lines derived
from in vitro activation with unrelated protein substances,
such as tetanus toxoid (unpublished data) or a protein extract
from previously defatted cypress pollen. Similarly, in vitro
[
 
3
 
H]thymidine incorporation in T cell lines was not stimu-
lated by incubation with neutral lipids extracted from cypress
pollen or with other pollen PLs, such as phosphatidyl-serine,
phosphatidyl-inositol, or phosphatidic acid (Fig. 3 c).
The type of antigen-presenting molecules involved in
presentation of PC and PE to specific T cell lines was inves-
tigated with the use of blocking mAbs. Pretreatment of au-
tologous DCs with anti-CD1a and CD1d mAbs inhibited
proliferation of most PL-specific T cell lines (Fig. 3 d).
Anti-CD1b, anti-CD1c, or anti-MHC mAbs did not mod-
ify the responses to cypress PLs. It is noteworthy that the
effects of antibodies specific for CD1a and CD1d on the
proliferative activity of PL-specific T cell lines correlated
Figure 3. Biochemical characterization of PLs extracted from 
cypress pollen. (a) Bidimensional TLC of PLs. The main species represented 
were phosphatidyl-choline (PC), phosphatidyl-ethanolamine (PE), phos-
phatidyl-serine (PS), phosphatidyl-inositol (PI), and free phosphatidic acid 
(PAc). (b) Electrospray ionization MS analysis of purified PC and PE from 
cypress pollen. (c) In vitro [3H]thymidine incorporation by T cell lines to 
pollen lipids or control protein (previously defatted) cypress pollen extract. 
(d) CD1 restriction of PC and PE recognition. Mean values   SD of single 
PC- and PE-specific T cell lines representative of all tested in triplicate. 
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strongly with the effects of these antibodies on the binding
of pollen grains by DCs (Fig. 2)
 
Isolation of PL-specific T cell clones
 
The CD1-restricted T cell lines were then cloned to identify
their fine antigenic specificity. Cloning efficiency was 9.5%
for PC- and 18% for PE-specific T cell lines. In contrast, us-
ing the same protocol of in vitro stimulation with cypress-
derived PLs, cloning efficiency in healthy normal subjects
was 0% for PC and 2% for PE. The majority of PL-specific
T cell clones produced both IL-4 and IFN-
 
 
 
, and thus were
identified as Th0 cells (unpublished data). Most T cell clones
derived from PC-specific T cell lines were CD4
 
 
 
, expressed
TCR
 
  
 
, and were mainly restricted by CD1a (Table I, top
section). Their fine antigen specificity was investigated using
synthetic PC species selected from the compositional analy-
ses shown in Fig. 3 b. The highest in vitro proliferation and
IL-4 production were observed to the predominant PC18:2/
18:2 species, a response comparable to the reactivity against a
natural pollen-derived PC mixture (Table I, top section).
Two CD4
 
 
 
 clones (1D3 and 3F9), with weak cypress PC
reactivity, responded in vitro to synthetic dipalmitoyl PC
(PC 16:0/16:0), a species not present in naturally occurring
cypress-derived PC. It is interesting to note that these T cell
clones displayed significant IL-4 production also after stimu-
lation with brain- and egg-derived PC (Table I, top section).
The 3F9 T cell clone was CD1a-restricted and expressed
V
 
 
 
24 and V
 
 
 
11 TCR gene segments based on specific mAb
staining. Only two of eight PC 18:2/18:2-specific T cell
clones were CD1d restricted. An overall weaker reactivity
 
Table I.  
 
Characteristics of phospholipid-specific T cell clones from cypress-sensitive subjects
 
Clone Phenotype CD1 restriction
 
Cypress
PC
16:0/16:0
PC
16:0/18:2
PC
18:1/16:0
PC
18:1/18:1
PC
18:2/18:2
PC
Brain
PC
Liver
PC
Egg
PC
1D3 TCR
 
  
 
+
 
CD4
 
+
 
CD1A + +++ 0 0 0 0 ++ 0 +
1G5 TCR
 
  
 
+
 
CD4
 
+
 
CD1A +++ 0 + 0 0 +++ 0 0 0
3F9 TCRV
 
  
 
24
 
+
 
CD4
 
+
 
CD1A + +++ 0 0 0 0 ++ 0 ++
3G1 TCR
 
  
 
+
 
CD4
 
+
 
CD1D ++ 0000 + + + 0 0 0
5A2 TCR
 
  
 
+
 
CD4
 
+
 
CD1A ++ 0 + 0 + ++++ 0 + 0
5B7 TCR
 
  
 
+
 
CD4
 
+
 
CD1A +++ 0 0 0 + ++ 0 + 0
5B9 TCR
 
  
 
+
 
CD4
 
+
 
CD1A + 0000 + + + 0 0 0
6D1 TCR
 
  
 
+
 
CD4
 
+
 
CD1D ++ 0 + 0 0 +++ 0 0 0
6D7 TCR
 
  
 
+
 
CD4
 
+
 
CD1A ++ 0000 + + 0 0 0
 
CD1 
 
Cypress
PE
16:0/16:0
PE
16:0/18:2
PE
18:1/18:1
PE
18:2/18:2
PE
16:0/18:2
PG
Brain
PE
Liver
PE
Egg
PE
B1.5 TCR
 
  
 
+
 
CD4
 
+
 
CD1D +++ 0 + 0 ++ 0 0 0 0
C2 TCR
 
  
 
+
 
CD4
 
+
 
CD1D +++ 0 ++ + ++ 0 0 0 0
D4 TCR
 
  
 
+
 
CD4
 
+
 
CD1D ++ 0000 + + + 0 0 0
E1.1 TCR
 
  +CD4+ CD1D +++ 0 0 0 ++ 0 0 0 0
F1 TCR  +CD4+ CD1D +++ 0 ++ 0 ++ 0 0 0 0
F3 TCR  +CD4+ CD1D +++ 0000 + + + 0 0 0
L5 TCR  +CD4+ CD1D +++ 0 ++ + 0 0 0 0 0
S7 TCRV 1+CD4+ CD1D +++ 0 +++ 0 + 0 0 0 ++
N3 TCRV 24+CD161+CD4 CD8  CD1D ++ 0 ++ 0 ++++ 0 0 + +
P3 TCR  +CD4+ CD1D ++ 0 ++ 0 +++ 0 0 0 0
P13 TCR  +CD4+ CD1D ++ 0000 + + + 0 0 0
EA3 TCR  +CD4+ CD1D +++ 0 +++ 0 ++ 0 0 0 +
EA6 TCRV 1+CD161+ CD1D + 0 ++++ 0 ++ 0 0 + 0
FA3 TCR  +CD4+CD161+ CD1D +++ 0 + 0 +++ 0 0 + 0
FA8 TCR  +CD4+ CD1D ++ 0 ++ 0 +++ 0 0 0 0
GA10 TCR  +CD4+ CD1D + 0 ++ 0 ++ 0 0 0 0
DD6 TCR  +CD4+CD161+ CD1D ++ 0000 + + 0 0 0
DE10 TCR  +CD4+ CD1D ++ 0 ++ + + 0 0 0 0
Q5 TCRV 1+CD4+CD161+ CD1A + +++ 0 0 0 0 ++ 0 ++
Antigen reactivity was measured by IL-4 production in 48 h culture supernatants: between 10 and 50 pg/ml (0), between 60 and 150 pg/ml ( ), between 160 and 250 pg/ml 
(  ), and over 260 pg/ml (   /    ).T CELL RECOGNITION OF LIPIDS FROM POLLENS | Agea et al. 300
was found against either PC 16:0/18:2 or PC 18:1/18:1,
whereas no proliferative response was recorded with PC 18:
1/16:0 as the stimulating agent (Table I).
The majority of T cell clones derived from allergic sub-
jects displayed reactivity toward cypress PE mixture (Table I,
bottom section). Only one clone (Q5) was purely CD1a re-
stricted. It reacted with PE 16:0/16:0 and to a lesser extent
with egg-derived PE, and expressed a    TCR that used
the V 1 gene product. Functionally, it secreted significant
amounts of IL-4 when exposed in vitro to PE 16:0/16:0 or
to egg-derived PE. Group II CD1d-restricted T cell clones
in this panel included one example that expressed the V 24/
V 11 iNKT cell-associated TCR (N3) and also one    T
cell clone (EA6) that coexpressed the NK marker CD161.
The iNKT cell clone N3 responded vigorously to cypress-
derived PE, as well as to synthetic PE 18:2/18:2, and to a
lesser extent toward liver-derived PE. Three CD4  clones
reacted exclusively with a phosphatidylglycerol 16:0/18:2,
whereas the majority reacted with either PE 16:0/18:2 or PE
18:2/18:2 or both of these PLs. In contrast, there were very
few clones with reactivity toward PE 18:1/18:1.
To examine the requirement for PL internalization by
APCs for CD1 presentation, we assessed the ability of HeLa
CD1d  transfectants to stimulate responses when subjected
to mild chemical fixation before loading with stimulating
PLs. The fixation of the APC surface prevents internaliza-
tion of CD1 or exogenous lipids to intracellular compart-
ments, which is required for some but not all previously
studied examples of lipid antigen presentation (30). Because
aldehyde fixatives caused strong augmentation of autoreac-
tivity of NKT cell clones to CD1d  APC, we instead used
the chemical cross-linker ECDI as a fixative (14). As il-
lustrated in the Fig. 4, the response of clones toward cy-
press-derived or synthetic PLs was substantially maintained
by CD1d  HeLa cells that had been subjected to fixation.
In particular, none of the selected clones (two CD4 
TCR    and one V 1  CD4 ) acquired autoreactivity
against HeLa CD1d , as demonstrated by the absence of
[3H]thymidine incorporation (mean: 585   250 cpm) with-
out adding exogenous PLs. In addition, antigen specificity
of tested clones was maintained in terms of IL-4 production
and proliferation.
Figure 4. Specificity of antigen recognition by PL-specific CD4  
    or     T cell clones. (a) Effect of fixation on PL presentation by 
CD1d-transfected HeLa cells. (b) IL-4 production by T cell clones after in 
vitro pulsing with cypress-derived or synthetic PLs. Note: for CD4     
clones, data are referred to C2, F1, and P3, for CD4 V 1  clones data are 
referred to S7 and EA6, whereas for CD4    CD161  data are referred to 
DD6 clone. All illustrated in Table I.
Table II.  Characteristics of PE-specific T cell clones from normal subjects
Clone Phenotype CD1 restriction
Cypress 
PE
16:0/16:0 
PE
16:0/18:2 
PE
18:1/18:1 
PE
18:2/18:2 
PE
16:0/18:2 
PG
Brain 
PE
Liver 
PE
Egg 
PE
NC-A2 TCR  +CD4+CD161+ CD1D + 0 + 0 0 ++ ++ 0 +++
NC-S22 TCR  +CD4+ CD1D ++ 0 ++ 0 ++ 0 + + ++
NC-D4 TCRV 24+CD161+
CD4 CD8 
CD1D + 0 0 0 0 ++ 0 ++ 0
NC-F.1 TCR  +CD4+ CD1D + 0 0 0 + 0 ++ ++ ++
NC-FP5 TCR  +CD4+ CD1D + 0 + 0 ++ 0 + + +++
Antigen reactivity was measured by IL-4 production in 48 h culture supernatants: between 10 and 50 pg/ml (0), between 60 and 150 pg/ml ( ), between 160 and 250 pg/ml 
(  ), and over 260 pg/ml.JEM VOL. 202, July 18, 2005 301
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Functional characteristics of CD1-restricted T cell clones 
with unconventional TCR
In some cases we have observed that T cell clones specific for
cypress-derived PLs did coexpress NK markers, or displayed
a particular TCR (Table I). In addition, they often respond
to PL mixtures of different origin with even greater [3H]thy-
midine incorporation as for cypress PLs. Because regulatory
functions have been described among CD1-restricted T cells,
mainly on the basis of their cytokine profile induced by en-
counter of environmental antigens (31), we searched for the
possibility that some of our clones could secrete, together
with IL-4 and IFN- , also IL-10 or TGF- 1 in response to
antigen stimulation. Among clones tested, we selected the
CD1a-restricted 16:0/16:0 PE-specific T cell clone Q5 co-
expressing CD161, CD4, and TCR V 1 receptor, the dou-
ble-negative CD161  V 24  V 11  CD1d-restricted T cell
clone (N3), which reacted with 18:2/18:2 PE and the CD4 
TCRV 24  clone, CD1a-restricted, specific for 16:0/16:0
PC (3F9). Functionally, all these clones were able to produce
both IL-4 and IFN-  after in vitro stimulation with cypress-
derived PL mixtures or corresponding synthetic lipid species
(Fig. 5). The Q5 T cell clone responded to egg-derived PE
mixture with multiple cytokine secretion, particularly TGF-
 1 (P   0.001). N3 T cell clone responded vigorously to cy-
press-derived PE, while displaying a weaker proliferative
response to liver-derived PE, with increase in IL-10 pro-
duction (P   0.05 vs. unstimulated cultures). Finally, the 3F9
clone showed discrete IL-10 and TGF- 1 production after
brain and egg PC mixtures stimulation (P   0.001 vs. un-
stimulated cultures). Such cytokine secretion pattern was not
influenced by the presence of CD1a  or CD1d  HeLa trans-
fectants, because the cytokine production in the absence of
added lipids was always negligible. Proliferative activity, as
measured by [3H]thymidine uptake, and cytokine secretion
patterns were concordant mainly for N3 T cell clone, which
is specific for 18:2/18:2 PE. The two other clones prolifer-
ated mainly in response to disaturated (16:0) PC or PE,
which are absent on cypress pollen PL extracts.
PL-specific T cell clones from nonallergic subjects
Although likely to be present at a significantly lower fre-
quency, CD1-restricted and PL-specific T cell clones could
also be isolated from normal nonallergic subjects. The phe-
notypic and functional characteristics of five such PE-spe-
cific T cell clones isolated from normal subjects are listed in
Table II. All but one were classical TCR     CD4  cells
and one (NC-D4) TCR V 24  CD161  CD4 and CD8
negative. Their responses to in vitro stimulation with cy-
press-derived PE were in all cases CD1d-restricted and
characterized by significant IL-4 production (ranging from
125 to 210 pg/ml). Of interest was their vigorous IL-4
production after stimulation with egg-, brain-, or liver-
derived PLs. This finding was quite different from the pat-
tern we observed in allergic subjects, in which there was a
clear bias toward responses to plant-derived PLs, as com-
pared with animal-derived ones (Table I).
Figure 5. Functional characteristics of selected PL-specific T cell 
clones. For cytokine production by T cell clones and proliferation assays, 
mitomycin C treated HeLa cells transfected with CD1a (for clones Q5 and 
3F9) or CD1d (for clone N3) were used as APCs. Stimulating antigens con-
sisted of 10  g/ml of cypress, brain, liver, and egg PL mixtures (PC or PE), 
as well as of synthetic PL species. Secreted IL-4, IL-10, TGF- 1, and IFN-  
(mean   SD of pg/ml in the supernatants of triplicate cultures) were 
measured after 48 h of culture by ELISA. [3H]thymidine incorporation 
(mean cpm   SD of triplicate cultures) after 5 d of culture was measured 
by scintillation counting. See Table I for CD1 restriction. T CELL RECOGNITION OF LIPIDS FROM POLLENS | Agea et al. 302
Correlation of PL-specific responses with atopic history 
and pollen exposure
Because cypress pollination in Italy is typically present from
January to March (32), we undertook a survey of the fre-
quency of PL-specific T cell lines over a 1-yr period. In al-
lergic patients, the average number and proportion of PL-
specific T cell lines recovered after in vitro culture paralleled
the presence of cypress pollen grains in the atmosphere, fol-
lowing the characteristic seasonal distribution (Fig. 6 a).
There were very few inducible PL-specific T cell lines in the
peripheral blood of normal controls or in the same allergic
subjects sampled during nonpollinating periods. The rele-
vance of this phenomenon was also assessed in freshly iso-
lated PBMC by exposing cells to cypress PLs and protein ex-
tracts, or to an irrelevant antigen, such as tetanus toxoid (Fig.
6 b). Cypress-sensitive subjects displayed in vitro prolifera-
tive responses to either lipid or protein cypress extracts, as
compared with Mycobacterium-exposed health care workers.
In normal controls we found in rare cases a slight [3H]thymi-
dine incorporation above the basal values, in line with results
obtained with the few PE-specific T cell clones we were
able to isolate from PBMC. Such results suggest that PL re-
activity of normal subjects, even if present at very low levels,
did not correlate with the seasonal cypress pollen count vari-
ations, as observed in allergic patients.
We also examined the reactivity of PL-specific T cell
lines derived from cypress-sensitive subjects to purified my-
colic acids from Mycobacterium tuberculosis, which has previ-
ously been identified as a CD1-presented lipid antigen in
humans (10, 11). Because IL-12 and IFN-  are powerful
suppressors of Th2 activity, lack of frequent exposure to in-
fections that stimulate production of these cytokines has
been speculated to increase the risk of developing atopy (33).
For instance, Bacillus Calmette-Guérin (BCG) infection of
mice either 4 or 12 wk before allergen airway challenge re-
sults in significant reduction of eosinophils within the lungs
with respect to uninfected controls (34). In humans, neona-
tal BCG vaccination or, alternatively, evidence of an immu-
nologic memory of this vaccination is associated with a re-
duced prevalence of allergic sensitization, asthma, eczema,
and hay fever during childhood (35).
Unlike previously published findings with human T
cell lines derived from in vitro stimulation with mycobac-
terial lipid products (36, 37), we did not find in allergic
subjects any significant reactivity to mycolic acid under our
experimental conditions (Fig. 6 c). In contrast, health care
workers with documented exposure to and latent infection
with M. tuberculosis responded in a CD1b- and CD1c-
restricted manner to mycolic acids, but did not respond to
cypress-derived PLs in vitro.
Role of PL-specific T cells in IgE production and in vivo 
hypersensitivity to pollen PLs
There is conflicting evidence from animal studies on the
requirement of classical CD1-restricted iNKT cells for the
development of various features of experimental allergy,
including high specific IgE production (19, 38–40) but this
function has not been assessed to our knowledge for other
subsets of CD1-restricted T cells. We tested the ability of
PE-specific TCR    CD4  cell clones, from both pa-
tients and controls, to help autologous B cells synthesize
IgE in vitro upon cypress PE stimulation. Clones derived
from allergic patients, but not from controls, were able to
induce IgE secretion when cocultured with autologous B
cells and stimulatory cypress PE or synthetic extracts, with
a less pronounced effect for those coexpressing CD161
(Fig. 7 a). However, such a helper effect on in vitro IgE
production couldn’t always reflect a similar behavior on
clinical allergic diseases. To evaluate the potential in vivo
significance of PL recognition in cypress pollen allergy, we
assessed cutaneous skin prick test reactivity to purified cy-
press-derived PLs and synthetic compounds (10  g/ml) in
allergic and healthy subjects. Negative control reagents,
which were represented by vehicle ethanol solution and
synthetic 16:0/16:0 PC or PE, caused a mild erythematous
Figure 6. Response to cypress pollen PLs in allergic subjects is specific 
and shows seasonal variability. (a) Correlation over a 1-yr period between 
atmospheric levels of cypress pollen (absolute counts, referred to the right 
y axis) in the region inhabited by the study subjects and the frequency of 
PL-specific T cell lines (percentage of responding T cell lines calculated over 
the total number obtained, referred to the left y axis). (b) Mean values 
( SD) of proliferative responses of PBMC to stimulation with cypress anti-
gens. A clear response (P   0.005) was seen in allergic, as compared with 
normal controls or M. tuberculosis exposed subjects. (c) CD1a- and CD1d-
restricted proliferative response in T cell lines of allergic subjects (top) toward 
pollen-derived PLs (10  g/ml; filled square), mycolic acid stimulation 
(10  g/ml; shaded square), or medium alone (open square). The bottom 
panel shows the responses of T cell lines derived from M. tuberculosis–
exposed subjects. One representative experiment of all performed in 14 
patients and 10 controls is depicted.JEM VOL. 202, July 18, 2005 303
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reaction never exceeding 2 mm maximal diameter in fore-
arms of healthy controls. Allergic subjects displayed a mean
5.27   1.23 mm diameter of reaction when tested with cy-
press-derived PLs, or with synthetic 18:2/18:2 PE, whereas
there was a 1.4   1.2 mm wheal and flare reaction with
negative control reagents. Moreover, they did not respond
to egg-, brain-, or liver-derived PL extracts (1.1   0.6
mm). No positive reactions to pollen-derived or synthetic
PLs were recorded in normal subjects or in Mycobacterium-
exposed heath care workers (wheal and flare diameters
0.92   0.43 mm; Fig. 7 b, left).
The presence of wheal and flare reactions against the
same PLs that were recognized by CD1-restricted T cells
suggested that these T cells might be responsible for the syn-
thesis of PL-specific IgE antibodies. In fact, in 6 out of 14 al-
lergic subjects there was a clear binding of circulating IgE to
18:2/18:2 PE-coated plastic wells, as revealed by the rise in
O.D. by more than 2 SD above that of controls (0.177  
0.076). The average of resulting values was significantly
higher in patients than in normal controls (Fig. 7 b, right).
DISCUSSION
Our studies have provided novel information concerning
recognition of lipid antigens by human T lymphocytes, and,
at the same time, they may shed new light on the mecha-
nisms governing the allergic immune response. The first im-
portant finding is that PLs from pollen membranes play a
crucial role in the early phases of the allergic immune re-
sponse because they are involved in the capture of pollen by
CD1  DCs, which is likely to be required for their subse-
quent recruitment of pollen-specific T cells. Nonbilayer PL
arrangements (hexagonally packed cylinders of the hexago-
nal tubular phase) occur in  40% of membrane lipids from
pollens, particularly phosphatidylserine, cardiolipin, PE, and
PC (20). Electron microscopy studies demonstrate that these
nonbilayer structures appear as protuberances on the surface
of the membrane (41). In this manner, acyl side chains of
PLs are exposed and may thus enter the CD1 pocket, mak-
ing the contact between pollen grain and DC stable. Al-
though we have not studied the mechanism allowing pollen
internalization by CD1 molecules in detail, this is the first
example to our knowledge of antigen-presenting molecules
that behave as receptors capable of binding to, and perhaps
favoring the uptake of the presented antigens. This feature is
likely the consequence of the unique capacity of CD1 mole-
cules to bind and exchange lipids also on the cell surface (9,
12, 42) and of the particular structural features of PLs on the
surface of pollen grain.
Obviously, CD1 molecules are unlikely to be the only
receptors by which APC can interact with pollens. APCs
Figure 7. IgE reactivity toward pollen PLs. (a) Two representative 
experiments of in vitro IgE production by autologous B cells cocultured 
with CD4  TCR    cell clones, expressing or not the CD161 molecule, 
and stimulated with cypress PE or synthetic PLs. Filled bars refer to clones 
from allergic subjects (clones B1.5 and FA8    CD161  and clone DD6 
   CD161 , as reported in Table I), open bars to those of normal controls 
(clone NC-FP5    CD161  and clone NC-A2    CD161 , as reported in 
Table II). *, P   0.001 with respect to unstimulated, 16:0/16:0 PE-stimulated 
or normal control clones. **, P   0.05 with respect to unstimulated cultures. 
(b) In the left panel is the average of mean wheal and flare reactions to 
cypress-derived PLs in study population. The right panel represents the 
circulating PE-specific IgE (mean OD at 405 nm) as detected by ELISA 
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posses a wide array of molecules (including scavenger re-
ceptors, mannose receptors, chemokine, and adhesion mol-
ecule receptors, etc.) for binding to diverse ligands (3, 43).
Pollen grains in general, or starch granules from grasses in
particular, possess also glycosylated constituents (mannose
residues, amylose, and amylopectine) in their external exine
membrane, which may interact with some of these recep-
tors. (44) That tree pollens in particular can use a CD1-
dependent interaction with mucosal DCs to gain access to
the deeper mucosal surfaces of allergic subjects is an intriguing
possibility, but will require further study for confirmation.
However, the recent demonstration that pollen-associated
lipid mediators, such as phytoprostanes, can modulate in vitro
some DC functions by inhibiting IL-12 p70 production and
potentiating their Th2-polarizing capacity toward naive T
cells seems to be in line with our observations and point out
the relevance of lipid pollen fractions (either secreted or mem-
brane associated) in influencing the adaptive DC-dependent
immune response (45).
Our results suggest that PC 18:2/18:2, a predominant
component of cypress PC, could be one of the specific tar-
gets in pollen grain capture and recognition by CD1a  DCs,
as well as a stimulating antigen for some responding T cell
clones from allergic subjects. There is increasing interest in
studying lipid antigens recognized in the context of CD1a,
particularly because the three-dimensional structure of this
molecule has recently been determined by x-ray crystallog-
raphy (46). In this regard, few CD1a-restricted clones have
been described so far. One of these was autoreactive and de-
rived from a patient with systemic lupus erythematosus,
whereas a second CD8  T cell clone was specific for myco-
bacterial antigen, which has recently been identified as a li-
popeptide (47). CD1a-restricted T cell clones that respond
to the common mammalian sphingoglycolipid sulfatide have
also been isolated from normal human subjects (10). More
recently a series of double-negative TCR     T cell clones
have been described that recognize Mycobacterium leprae–
derived nonpeptide antigens in the context of CD1a 
Langerhans dendritic cells (48). Before our study, no CD1a-
restricted PL-specific T cell clones had been reported, nor had
membrane PL been demonstrated to be involved in CD1a-
mediated pollen grain capture. Langerhans-derived DCs in
the epidermis adopted the C-type lectin langerin, a pattern
recognition receptor of the innate immune system, to cap-
ture sugar-containing nonpeptide molecules (42). The CD1-
mediated PL binding and uptake described in the current
study could represent an adaptive response of the immune
system that facilitate this type of restriction in allergic sub-
jects, because CD1a  or CD1d  DCs are uniformly absent
in the airways of normal subjects (25).
Another interesting antigen specificity was noted toward
PC 16:0/16:0, a species not present as a component of PL
mixtures extracted from cypress pollen. This antigen speci-
ficity might represent a novel example of epitope spreading
during the immune response (49), in which the initial reac-
tivity against pollen PLs may recruit T cells with higher
avidity for different PL antigens. The physiological roles of
these T cells after encountering an environmental antigen at
mucosal surfaces could be to protect the host from poten-
tially dangerous dietary or inhaled products, as well as to re-
strain any tendency toward autoreactivity or damaging hy-
persensitivity, as demonstrated by the cytokine secretion
pattern (similar to that of regulatory T cells) they acquire
when pulsed with stimulating PLs (50). Alternatively, be-
cause PC 16:0/16:0 is the most abundant PL present in the
pulmonary surfactant (51), it may become a cross-reacting
autoantigen in allergic patients with important clinical con-
sequences. Indeed, the PL composition of human respiratory
surfactant is frequently altered during allergic respiratory dis-
eases (52, 53). It is interesting to speculate that cross-reactiv-
ity between similar surfactant PL compounds containing
palmitate acyl chains and allergen-triggered reactivity of mu-
cosal T cells against PLs in asthmatic airways may perhaps
explain the worsening of airway inflammation observed in
asthmatic patients treated with natural porcine surfactant and
then challenged in vivo with allergen (54).
There are few descriptions of CD1d-mediated recogni-
tion of PLs by T cells. It was previously noted that biotinyl-
ated PE 16:0/16:0 can bind human CD1d molecules on
APC, although this did not lead to stimulation of CD1d-
restricted NKT cell hybridomas specific for the glycolipid
 -galactosyl-ceramide (55). One murine V 14i NKT cell hy-
bridoma reactive to CD1d transfected tumor cells was found
to respond strongly to purified PE, PG, and PI, identified as
potential self-antigens presented by mCD1d1 to regulatory
NKT cells (26). More recently, the same NKT cell hybrid-
oma was found to recognize also natural PEs of other cellular
origins, including Escherichia coli, mammalian tissues, and soy-
bean (18). Such recognition correlated with the degree of un-
saturation of the PEs, with plant PE being the most potent
activator. Our data confirm that plant-derived, unsaturated
PE are the main PL antigens recognized by a variety of T cell
clones derived from allergic subjects, which consist mainly of
TCR     CD4  clones. Therefore, the nature of the acyl
chains in the lipid antigens contributes enormously to immu-
nogenicity. This appears a general phenomenon, not limited
to one TCR. Apart from the theoretical cross-reactivity with
some constituents of human surfactant, such T cell clones dis-
play a limited reactivity toward PL extracted from mamma-
lian tissues, such as liver- and brain tissue–derived PLs. Thus,
autoreactivity, although not completely excluded, does not
seems to be their major functional property.
The clones isolated from allergic subjects showed a ten-
dency to produce both IFN-  and IL-4, thus suggesting that
they participate in both inflammatory and allergic responses.
Regarding the latter, the observed in vitro IL-4 response to
cypress-derived PLs by PBMC from allergic subjects, and
the functional T helper activity for IgE production, seems to
indicate that most PL-specific    CD4  and     T cell
clones could be viewed as predominantly of the Th2-type.JEM VOL. 202, July 18, 2005 305
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Such a conclusion can be drawn not only on the basis of
functional in vitro testing, but also in consideration of the
presented evidence of cutaneous immediate reactivity to-
ward cypress PLs and the demonstration that circulating IgE
antibodies specific for these antigens do exist in allergic sub-
jects. Such findings are in keeping with previous reports (56,
57) and, more generally, with helper activity by CD1-
restricted T cells (58). The contribution of PL-specific T cells
to allergic reactions in the lung of pollen-sensitive patients is
not demonstrable with in vitro experiments, and therefore
we can only speculate about their role in the pathogenesis of
this disease. Lipid-reactive T cells, such as iNKT cells ex-
pressing the invariant TCR V 14 have been associated with
the establishment of allergic reactions in mouse experimental
models of allergy (19, 38, 59). Whereas the ligands respon-
sible for triggering iNKT cells in these models are not
currently known, our studies have identified T cells with
known antigen specificities that might have important func-
tions. In the case that plant PL–specific T cells are activated
in the lung, they could locally exert their effector functions.
This is in keeping with the presence in the respiratory tract
of asthmatic subjects of CD1d  and CD1a  DCs coexpress-
ing the CD86 molecule (60, 61), and of CD1d  DCs in the
lamina propria of the duodenal mucosa of cow’s milk-sensi-
tive subjects (62).
In conclusion, the CD1-restricted T cell clones described
in the current study represent, to our knowledge, the first
description of human T cell populations able to recognize
naturally occurring foreign PLs associated with a strong en-
vironmental allergen and with a clinical evidence of allergic
disease. CD1 molecules play a fundamental role in the pre-
sentation of microbial antigens, and a regulatory role for
CD1d-restricted NKT cells has been strengthened by a
number of recent studies (63, 64, 65). Now a new piece can
be added to the puzzle, linking such T cell subpopulations to
the control of host reactivity against autologous PLs and to
environmental allergens, such as the lipids present in tree
pollen membranes.
MATERIALS AND METHODS
Phospholipids. Unless stated otherwise, all PLs were obtained commer-
cially and used without further purification. Dipalmitoyl-sn-glycero-3-phos-
phocholine (PC 16:0/16:0), 1-palmitoyl-2-linoleoyl-sn-glycero-3-phospho-
choline (PC 16:0/18:2), 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine
(PC 18:1/16:0), 1,2-di[(cis)-9-octadecenoyl]-sn-glycero-3-phosphocholine
(PC 18:1/18:1), dilinoleoyl-sn-glycero-3-phosphocholine (PC 18:2/18:2),
1-palmitoyl-2-linoleoyl-sn-glycero-3-phoshpho-rac-(1-glycerol) sodium salt
(PG 16:0/18:2), and dilinoleoyl-sn-glycero-3-phosphoethanolamine (PE 18:
2/18:2) were purchased from Avanti Polar Lipids, Inc. Dipalmitoyl-sn-glyc-
ero-3-phosphoethanolamine (PE 16:0/16:0), 1,2-Di[(cis)-9-octadecenoyl]-
sn-glycero-3-phosphoethanolamine (PE 18:1/18:1), and 1-hexadecanoyl-2-
[(cis,cis)-9,12-octadecadienoyl]-sn-glycero-3-phosphoethanolamine (PE 16:
0/18:2) were purchased from Sigma-Aldrich. Naturally occurring PC and
PE from egg yolk, liver, or brain tissue were obtained from Avanti Polar
Lipids, Inc. All PLs suspensions were prepared in absolute ethanol.
Preparation of cypress pollen lipids. Lipids were extracted from pol-
len after the procedure of Folch et al. (66). The methanol/chloroform ex-
tract was evaporated nearly to dryness under N2 and chromatographed on
silica gel G TLC plates, using chloroform/methanol/water (65: 25: 4 by vol),
as the solvent. Phospholipid classes were separated by two-dimensional TLC
(6.5   6.5 cm; PE SIL G 250  m; Whatman) with (a) chloroform/metha-
nol/1.6 M ammonia (70:30:5, by volume) and (b) chloroform/methanol/ace-
tone/acetic acid/water (75:15:30:15:7.5 by volume). Spots were revealed
by staining with dichlorofluorescein, scraped off the plate, and eluted with
chloroform/methanol/acetic acid/water (50:39:1:10 by volume). Samples
were freed from dichlorofluorescein by washing three times with 3 ml of 4 N
ammonia and three times with methanol/water (45:10 by vol). Trace
amount of silica gel were removed by centrifugation. Finally, PLs were
quantified by phosphorus assay after digestion with 70% perchloric acid (67).
Electrospray ionization mass spectroscopy of cypress pollen PLs.
ESI mass spectrometric analysis was performed on a triple-quadruple tan-
dem mass spectrometer (Quattro Ultima; Micromass) equipped with an ESI
interface. Total PL extracts were dissolved in 25  l of methanol/chloro-
form/water/NH4OH (7:2:0.8:0.2, vol/vol) for single stage and tandem MS
analysis of PC and PE and were analyzed by nanospray ESI–MS. Dry-
heated nitrogen was used as both the cone and desolvation gas (70 and
450/l h, respectively) and dry argon was used as the collision gas (3.5  
10 3 mbar). All data was recorded at mass resolution, as a signal average of
10 scans/collection, with a scan time of 12 s.
PC species were detected by positive ionization, whereas PE was pref-
erentially detected using negative ionization. After fragmentation with ar-
gon gas, PC molecules produced a fragment with m/z 184 , corresponding
to the protonated phosphocholine headgroup, and precursor scans of the
m/z184 moiety provided diagnostic determination of PC. Identities of PE
species were determined by neutral loss scans of phosphoethanolamine (m/z
141 ). The predominant molecular species present for each ion peak re-
solved was determined by analysis of fatty acyl fragments generated by colli-
sion gas-induced fragmentation under negative ionization. The major pre-
cursor ion for PC in negative ionization represented loss of one methyl
group [M-15] , whereas for PE the molecular ion [M-H]  was fragmented.
Study subjects and cell sources. 14 cypress-sensitive subjects (eight
males and six females, age range 19–45 yr) were enrolled in the study on
the basis of the concordance between their clinical history (January to
March rhinoconjunctivitis and/or asthma) and the results of cutaneous
skin prick tests and serum specific IgE levels, as detected with commercial
reagents. We avoided enrollment of sensitive subjects who clinically expe-
rienced symptoms also in other months of the year, indicating a broader
allergen sensitization (including dust mites, Parietaria officinalis, or Grami-
naceae). This selection is in line with the epidemiological characteristics of
cypress-sensitive adult population in the Mediterranean area (32), in
which 84% of cases with the above-mentioned characteristics are repre-
sented by monosensitive subjects with scarce evidence of atopic inherit-
ance in their families and in which symptoms related to cypress allergy of-
ten develop in adult age. Controls were represented by two distinct
groups of age-and sex-matched subjects: 10 health care workers with doc-
umented exposure to and latent infection with M. tuberculosis and 10
healthy subjects without clinically evident allergic diseases.
BAL samples from five cypress-sensitive, nine adjunctive dust mite-sensi-
tive asthmatic subjects, and from 10 normal volunteers were used as sources of
pulmonary macrophages/dendritic cells for morphological and immunocy-
tochemical studies. Informed consent to all invasive procedures was obtained
from participants and the study was approved by the local Ethical Committee.
Peripheral blood from the cypress-sensitive subjects, health care workers,
and 10 normal controls were repeatedly collected during 1 yr. Processed sam-
ples were centrifuged over a Ficoll-Hypaque density gradient and mononuclear
cells resuspended in RPMI 1640 supplemented with 10% FCS (GIBCO BRL).
Circulating adherent monocytes were differentiated in vitro into DCs by cul-
turing with rhGM–CSF (25 ng/ml; EuroClone) and recombinant human inter-
leukin 4 (rhIL-4; 200 U/ml; EuroClone) for 5 d and used as CD1  APC.T CELL RECOGNITION OF LIPIDS FROM POLLENS | Agea et al. 306
Evaluation of pollen grain–dendritic cell interactions. Immunophe-
notyping was performed on BAL mononuclear cell suspensions, as previ-
ously described (39), by means of the following mAbs: purified anti–human
CD11c (clone BU15; Serotec), CD80 and CD86 (clones BB1 and BU63;
Ancell), followed by fluorescein-conjugated goat anti–mouse Ab of appro-
priate isotype controls (Southern Biotechnology Associates, Inc.). For mor-
phological observation, cytospin preparations of BAL mononuclear cell sus-
pensions (0.5   106/ml) were stained with May-Grünwald-Giemsa,
whereas for immunocytochemistry preparations CD1d molecules were
detected by labeling with anti-CD1d mAb (clone NOR3.2; Serotec) at
working dilution of 0.2  g/ml, and further developed by a three-stage im-
muno–alkaline phosphatase/antialkaline phosphatase  technique, as previ-
ously described (39).
Monocyte-derived DC (106/ml) were incubated on polylysine-treated
coverslips with cypress pollen (5   104 grains/ml) for 30 min at 37 C. Ad-
herence of grains to the cells was scored at 30 min. For each preparation,
500 cells were counted by each of three independent observers, who were
blinded to the identity of the samples, and the percentages   SD of cells
with bound grains were calculated. Phase-contrast images were obtained
with an Olympus AX70 microscope through a SPOT-RT cooled color
digital camera (Diagnostic Instruments) with the SPOT-RT 3.1 software.
For receptor-mediated inhibition of pollen grain adhesion, the DC suspen-
sions were preincubated with the following purified mAbs (20  g/ml):
anti–human CD1a (clone NA1/34), CD1b (clone M-T101), CD1c (clone
L161), and CD1d (clone NOR3.2; all from Serotec), anti-MHC class I and
II (clones G46-2.6 and G46-6; BD Biosciences). For receptor blockade, cy-
press-derived PLs were administered to dendritic cells at various concentra-
tions, ranging from 0.1 to 10  g/ml. Subsequent pollen adhesion was eval-
uated described before. In some adhesion experiments the HeLa cell line,
mock, or CD1d transfected (14), was adopted with the same experimental
procedure described above for DC. The time-course of pollen grain inges-
tion was evaluated on dendritic cells incubated at 37 C with 4-[4-(dihexa-
decylamino)styryl]-N-methylquinolinium iodine (DiQ; Molecular Probes)
at the labeling concentration of 1  M for 45 min. Images were obtained
using a confocal apparatus (MRC-1024; Bio-Rad Laboratories, Inc.)
equipped with an krypton-argon laser on Olympus IMT-2 inverted micro-
scope using a 60 , 1.4 NA objective. 0.1 mM fluorescein diacetate (Mo-
lecular Probes) in PBS was adopted for labeling pollen grain suspensions.
Generation of PL-specific T cell lines and clones. 0.5–1   106 non-
adherent PBMC per ml from each sample (the 14 cypress-sensitive and the
10 healthy subjects) were cultured in RPMI 1640 medium supplemented
with 2 mM L-glutamine (GIBCO BRL), 20  M 2-mercaptoethanol, 100
U/ml penicillin, 50  g/ml streptomycin (complete medium), and 10% FCS
with autologous dendritic cells in 24-well flat-bottomed culture plates
(Costar Corporation) in a final volume of 3 ml. A total of six wells per sub-
ject were run at each collection time point during one year (i.e., every
month from December to March, and every two months thereafter). Cells
were exposed to TLC-purified cypress-derived PC and PE (10  g/ml)
without adding cytokines or growth factors and restimulated every 2 wk
with CD1  autologous DC plus cypress PL extracts. PBMC of control M.
tuberculosis–exposed health care workers were cultured as above with 10  g/
ml mycolic acid (Sigma-Aldrich) dissolved in absolute ethanol. Proliferating
lines were further expanded with recombinant human interleukin 2 (rhIL-2;
50–100 U/ml; EuroClone) and then tested in vitro for antigen specificity, as
previously described in detail (15).
For limiting-dilution cloning of PL-specific T cell lines, T cell blasts
were seeded at 0.5, 1, and 2 cells per well in 96-well round-bottomed plates
(Nunclone) with 105 irradiated (5,000 rads) autologous T cell–depleted
PBMC as feeder cells, 1:2,000 (final dilution) PHA-P (Difco) and rIL-2 (20
U/ml) in complete medium supplemented with 10% heat-inactivated hu-
man AB serum. Growing microcultures were then expanded at weekly in-
tervals with 105 irradiated feeder cells and rIL-2. To expand established
clones, T cell blasts were restimulated every 3 wk with 0.1% PHA-P and ir-
radiated autologous feeder cells.
Immunophenotype of emerging clones was detected by flow cytome-
try with the following mAbs: Cy-chrome–conjugated anti-CD4 (clone
RPA-T4; BD Biosciences), phycoerythrin-conjugated anti-V 11 (clone
C21; Serotec), fluorescein (FITC)-conjugated anti-CD161 (NKR-P1A Ag,
clone DX12; BD Biosciences), anti-CD8 (clone LT8; Serotec), anti-  
(clone BMA031; Serotec), anti V 24 (clone C15; Serotec), anti-pan TCR
   (clone 5A6.E9; T Cell Diagnostics) or -V 9 (clone 7A5; T Cell Diag-
nostics), -V 1, and -V 2 (clones TS-1 and 15D; all from T Cell Diagnos-
tics). In some experiments three-color immunofluorescence data were ana-
lyzed on gated Cy-chrome-CD4  cells. Forward and side light scatter was
used to optimize gating of lymphocytes, and fluorescence analysis was per-
formed using Lysis II software (Becton Dickinson)
Functional characterization of PL-specific T cells. For evaluation of
CD1 restriction, T cell lines and clones were stimulated in the presence or
absence of mAbs directed toward single CD1 epitopes (i.e., anti-CD1a, b,
c, and d; Serotec) at working concentration of 20  g/ml. Control experi-
ments were performed with mouse IgG, anti-MHC class I and II mAbs (as
mentioned in the Evaluation of pollen grain–dendritic cell interactions sec-
tion). Stable CD1 transfectants of cervical carcinoma cell line HeLa or C1R
lymphoblastoid B cell line expressing CD1a, CD1b, CD1c, or CD1d and
CD1-negative mock transfectants, have been previously described (68). Mi-
tomycin C–treated (1 h at 37 C with 150  g/ml; Sigma-Aldrich) or irradi-
ated (50 Gy) CD1 transfectants (105 per well) were seeded with cloned T
cells (2   104 per well) in a 96–round-bottom plate (Costar) in 0.2 ml me-
dium alone or containing either PC or PE (from 1 to 20  g/ml). After cul-
turing for 96 h in 5% CO2 atmosphere, wells were pulsed with 1  Ci of
[3H]thymidine and harvested 16 h later for   scintillation counting using a
scintillation counter (Beckman Coulter). Results were expressed as mean
cpm (  SD) of triplicate culture wells.
For experiments examining PL presentation by fixed APCs, mock- or
CD1d-transfected HeLa cells were incubated for 1 h on ice with 2 ml 0.9%
NaCl containing 75 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiim-
ide-HCl (ECDI; Pierce Chemical Co.) followed by extensive washing in
RPMI 1640.
Specific response and CD1 restrictions were evaluated by [3H]thymi-
dine incorporation, as above, after 5 d of culture, and/or by measurement of
IL-4 (Immunotech) and IFN-  (R & D Systems) production using com-
mercial kits with supernatants recovered after 48 h.
For measurement of helper activity for in vitro IgE production, T cell
clones (105 cells per well) were cocultured with autologous T cell depleted
PBMC (105 per well) as a source of B cells for 10 d in a final volume of 0.2 ml,
and IgE levels were measured in the supernatants of stimulated samples by cap-
ture ELISA. The mouse IgM for human IgE capture (clone HP 6061) was pur-
chased from Southern Biotechnology Associates, Inc. Immunoplates (Nunc)
were coated overnight at 4 C with the capture antibody diluted in 0.1 M bicar-
bonate buffer. Blocking was performed by adding 2% bovine serum albumin/
Tris-buffered saline for 1 h, followed by several washings. Supernatants and in-
ternal standards were then added to the wells and incubated in duplicate for 2 h.
After several washes, the biotinylated anti–human IgE detection mAb (clone
HP6029; Southern Biotechnology Associates, Inc.) was added. Plates were in-
cubated for another hour with alkaline phosphatase–conjugated streptavidin.
After the final reaction with phosphatase substrate (Sigma-Aldrich), plates were
read in a microplate ELISA reader at 405 nm, and the amount of IgE was cal-
culated according to the standard curve. The variations of readings in duplicate
cultures never exceeded 15%. Values are expressed in nanograms/milliliter.
In vivo evaluation of IgE reactivity against pollen PLs. Purified cy-
press-derived and synthetic PLs were dissolved in absolute ethanol and used
for skin prick tests at the working concentration of 10  g/ml. 100  l of PL
solution was applied over the skin of forearms of allergic and control sub-
jects, and, after puncturing with a sterile lancet, the mean wheal and flare
reaction maximal diameters (mm   SD) were measured after 15 min.
Circulating specific IgE to PLs were measured by an ELISA assay. In
brief, half the wells of microtiter ELISA plates (Polysorp; Nunc) wereJEM VOL. 202, July 18, 2005 307
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coated with each of the following anionic PLs at 50  g/ml: synthetic dili-
noleoyl-sn-glycero-3-phosphoethanolamine (PE 18:2/18:2, from Avanti
Polar Lipids, Inc.) and cypress-derived PE in ethanol, the other half with
ethanol alone, and air dried overnight at 4 C. After blocking with 1% serum
albumin (Sigma-Aldrich) in Tris for 1 h at 37 C and three washes with PBS,
serum diluted 1:10 in 1% Tris/albumin was added in duplicate to both PL-
coated and -uncoated halves of the plates. After incubation for 3 h at 37 C
and three washes with PBS, alkaline phosphatase-conjugated goat anti–
human IgE (Southern Biotechnology Associates, Inc.) was added at 1:1,000
dilution, for 1 h at 37 C. Color was developed by adding dinitrophenyl
phosphate (1 mg/ml [Sigma-Aldrich] solution containing 1 M MgCl2 in bi-
carbonate buffer, pH 9.6, after three washes with PBS and two with bicar-
bonate buffer. The plates were incubated at 37 C and read after 1 h at 405
nm (with reference 490 nm). Background values were obtained from wells
containing no antigen, and their absorbances subtracted from all sample
readings. The results were expressed as a mean OD. Values  2 SDs above
the mean of healthy controls were deemed to be positive.
Statistical analysis. Study populations were stratified according to age
and sex. Statistical comparison in dendritic cell–pollen adhesion experi-
ments and in T cell proliferation assays were calculated by the Mann-Whit-
ney U test. We used Kruskall-Wallis one-way analysis of variance (with a
significance level of 0.05) for statistical evaluation of the differences in cyto-
kine production, IgE secretion by different T cell clones and circulating
specific IgE assay. The Statistical Package for the Social Sciences (SPSS,
Inc.), version 11.0, was used for all statistical computations.
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